Menu

Blog

Jan 30, 2019

Leprosy Vaccine Candidate Moves Into Human Trials

Posted by in category: biotech/medical

Hansen’s disease, which is commonly known as leprosy, is among the leading causes of non-traumatic, peripheral neuropathies around the world.

The World Health Organization (WHO) initiated its ‘Leprosy Elimination Project’ during the 1980s with great results, curing more than 14 million cases.

Leprosy is caused by Mycobacterium leprae, with the infection progressing to cause disfiguration of the skin and mucous membranes, as well as progressive and irreversible nerve damage.

Read more

Comments are closed.